global
gene
express
investig
provid
inform
regard
host
respons
emerg
reemerg
pathogen
level
individu
gene
gene
cluster
howev
pauciti
inform
regard
relationship
cell
signal
network
particular
activ
statu
biologicalpatholog
event
occur
throughout
infect
well
establish
mani
biolog
process
regul
independ
transcript
translat
chang
posttransl
modif
ptm
event
inde
kinasemedi
phosphoryl
protein
kinas
catalyz
transfer
phosphat
group
atp
hydroxyl
group
specif
ser
thr
tyr
residu
among
thoroughli
character
ptm
virtual
cell
signal
transduct
event
regul
kinas
independ
biolog
complex
host
ie
prokaryot
eukaryot
lend
credenc
biolog
import
kinas
kinas
identifi
human
genom
human
proteom
modul
kinasemedi
phosphoryl
thu
consid
central
role
kinas
broad
rang
cellular
process
includ
growth
develop
metabol
immun
respons
postul
activ
individu
kinas
may
repres
reliabl
predictor
cellular
phenotyp
transcript
translat
inde
transcript
translationalbas
omic
approach
often
unabl
account
regulatori
event
includ
gene
silenc
mrna
stabil
translat
effici
protein
turnov
enzymesubstr
subcellular
sequestr
protein
activationrepress
given
central
role
kinas
regul
biolog
process
kinas
logic
drug
target
testament
kinas
inhibitor
grant
licensur
us
food
drug
administr
fda
broad
rang
malign
continu
increas
number
kinas
inhibitor
variou
stage
preclin
trial
furthermor
kinas
second
frequent
target
gene
class
cancer
therapi
g
protein
coupl
recent
priorit
repurpos
approv
therapeut
altern
malign
nation
institut
health
center
advanc
translat
scienc
ncat
also
provid
consider
impetu
investig
licens
kinas
inhibitor
infecti
diseas
therapeut
concern
exist
regard
therapeut
applic
kinas
inhibitor
novel
therapeut
infecti
diseas
particular
potenti
immunosuppress
effect
follow
prolong
treatment
howev
appreci
applic
kinas
inhibitor
case
would
need
target
term
time
dose
appropri
molecular
biomark
guid
initi
cessat
also
appreci
clinic
symptom
associ
mani
emerg
reemerg
pathogen
associ
dysregul
host
immun
respons
particular
proinflammatori
respons
thu
global
analysi
activ
state
host
kinas
kinom
provid
critic
insight
specif
activ
state
individu
kinas
cell
signal
pathway
larger
biolog
network
addit
kinom
investig
may
offer
import
predict
insight
cellular
mechan
regul
phenotyp
chang
within
mani
kinas
recogn
particular
phosphoryl
motif
compos
central
phosphoacceptor
site
amino
acid
residu
central
phosphoryl
peptid
repres
kinas
target
motif
synthes
rel
high
effici
low
expens
inde
kinas
target
motif
peptid
shown
appropri
substrat
respect
kinas
vmax
km
valu
approach
fulllength
thu
peptid
kinom
array
construct
analog
manner
tradit
dna
microarray
kinas
target
motif
peptid
spot
onto
glass
slide
repres
hundr
thousand
uniqu
peptid
target
kinas
figur
follow
sampl
form
cellular
lysat
whole
organ
tissu
individu
cell
type
appli
kinom
peptid
array
allow
phosphoryl
specif
peptid
target
kinas
within
lysat
figur
develop
kinomespecif
bioinformat
analysi
softwar
includ
platform
intellig
integr
kinom
analysi
piika
provid
mechan
identifi
complex
pattern
kinasemedi
phosphoryl
event
quantit
differ
compar
syndrom
casedefinit
mer
infect
requir
compat
clinic
syndrom
epidemiolog
risk
factor
includ
travel
affect
region
contact
known
suspect
case
initi
symptom
merscov
infect
includ
fever
chill
cough
short
breath
myalgia
malais
follow
mean
incub
period
day
rang
mildli
symptomat
possibl
asymptomat
infect
report
progress
sever
diseas
associ
preexist
medic
condit
includ
cardiopulmonari
diseas
obes
diabet
report
mer
case
among
adult
median
age
year
sever
case
respiratori
failur
requir
mechan
ventil
typic
occur
within
day
symptom
laboratori
abnorm
includ
lymphopenia
leukopenia
thrombocytopenia
elev
serum
creatinin
level
consist
acut
kidney
injuri
elev
liver
high
lactat
level
consumpt
coagulopathi
also
chest
radiograph
abnorm
observ
case
consist
viral
pneumon
secondari
bacteri
pneumonia
acut
respiratori
distress
data
character
immun
respons
merscov
infect
limit
faur
et
al
evalu
cytokin
level
serum
bronchoalveolar
lavag
bal
two
mer
patient
one
fatal
diseas
one
higher
level
retino
acidinduc
gene
melanoma
differentiationassoci
protein
interferon
regulatori
factor
irf
interleukin
il
lower
level
observ
fatal
case
compar
survivor
recent
min
et
al
perform
tempor
analysi
cytokin
chemokin
growth
factor
blood
level
patient
recent
outbreak
mer
south
patient
subcategor
four
group
basi
diseas
sever
group
patient
develop
fever
recov
group
ii
patient
develop
mild
pneumonia
without
hypoxemia
group
iii
patient
prolong
sever
pneumonia
group
iv
patient
sever
pneumonia
acut
respiratori
distress
syndrom
group
iv
patient
includ
five
fatal
case
mer
patient
group
fulli
recov
ill
elev
group
larg
peak
second
week
ill
granulocytecoloni
stimul
factor
gcsf
granulocyt
macrophag
gm
csf
similarli
elev
across
patient
group
howev
patient
fatal
diseas
reduc
gmcsf
respons
follow
antivir
treatment
compar
patient
recov
patient
pneumonia
rel
elev
tumor
necrosi
factor
tnf
second
third
week
ill
elev
appear
trend
posit
sever
ill
robust
induct
multipl
chemokin
found
patient
notabl
eotaxin
regul
activ
normal
express
secret
rant
elev
patient
contrast
monocyt
chemotact
protein
mcp
macrophag
inflammatori
protein
mip
promin
group
ii
iii
compar
group
iv
furthermor
elev
interferon
gamma
induc
protein
ip
correl
develop
pneumonia
group
multipl
growth
factor
includ
epiderm
growth
factor
egf
fibroblast
growth
factor
fgf
vascular
endotheli
growth
factor
vegf
significantli
elev
across
patient
howev
egf
significantli
higher
patient
recov
diseas
compar
fatal
case
evalu
need
character
natur
histori
immun
respons
acut
merscov
infect
recoveri
effort
better
character
merscov
pathogenesi
absenc
avail
sampl
human
patient
particular
address
patholog
chang
associ
infect
multipl
anim
speci
employ
merscov
investig
multipl
small
anim
suscept
merscov
rhesu
macaqu
marmoset
develop
mild
sever
lung
patholog
follow
experiment
infect
transcriptom
analysi
merscovinfect
rhesu
macaqu
reveal
gene
relat
antivir
immun
chemotaxi
inflamm
overexpress
lesion
versu
grossli
normal
lung
tissu
day
significantli
smaller
number
differenti
express
gene
found
day
postinfect
obviou
trend
follow
pathway
enrich
analysi
signific
chang
transcriptom
profil
peripher
blood
mononuclear
cell
pbmc
observ
day
postinfect
global
analysi
suggest
key
role
initi
rapid
innat
immun
inflammatori
respons
pattern
recognit
receptor
follow
rapid
studi
merscovinfect
marmoset
evalu
lung
lesion
rnaseq
day
pathway
analys
demonstr
chemotaxi
cell
migrat
cell
cycl
progress
cell
prolifer
fibrogenesi
highli
overrepres
rel
uninfect
control
lesser
degre
pathway
associ
inflamm
vascular
endotheli
activ
prolifer
smooth
muscl
tissu
repair
also
overrepres
infect
anim
differ
signific
day
postinfect
ill
progress
rel
day
recent
menacheri
colleagu
examin
interact
merscov
host
ifnstimul
gene
isg
respons
isg
respons
merscov
infect
cell
lung
adenocarcinoma
cell
line
discern
induct
initi
upon
infect
upregul
h
downregul
subset
isg
result
alter
histon
modif
potenti
epigenet
contributor
earli
impair
antivir
cellular
defens
separ
analysi
genet
distinct
merscov
strain
merscov
merscov
produc
distinct
gene
express
profil
analys
may
better
inform
earli
hostcel
antivir
respons
impact
viral
evolut
complex
biolog
respons
proteom
analysi
corrobor
transcript
data
induct
isg
observ
h
postinfect
significantli
reduc
level
pkr
compar
uninfect
control
also
note
differenti
host
transcriptom
respons
merscov
merscov
highlight
propens
emerg
viral
pathogen
evolv
rapidli
import
addit
host
respons
analys
augment
clarifi
complex
biolog
respons
host
respons
merscov
infect
kinom
analysi
recent
assess
use
cell
immort
human
hepatocyt
cell
line
highli
permiss
merscov
tempor
analysi
kinom
respons
peptid
array
reveal
select
modul
extracellular
signalregul
kinas
erk
mitogenactiv
protein
kinas
mapk
akt
also
known
protein
kinas
b
mechanist
target
rapamycin
mtor
signal
respons
overrepresent
analysi
ora
reveal
erkmapk
signal
respons
consist
upregul
infect
multipl
erkmapk
famili
member
form
central
compon
function
network
signal
pathway
throughout
infect
similar
result
observ
intermedi
signal
pathway
h
postinfect
suggest
modul
erkmapk
signal
may
import
product
merscov
infect
downstream
analysi
phosphoryl
pattern
pathway
intermedi
erkmapk
signal
support
observ
kinom
analysi
investig
demonstr
nuclear
factor
kappalightchainenhanc
activ
b
cell
regul
famili
member
import
mediat
merscov
ifnmedi
signal
also
modul
merscov
infect
consist
prior
result
also
agreement
vitro
transcript
analysi
merscov
prophylact
therapeut
addit
fdalicens
kinas
inhibitor
target
activ
kinas
merscov
infect
impair
viral
replic
hypothesisgener
data
may
inform
direct
investig
merscov
pathogenesi
importantli
demonstr
potenti
identifi
novel
hostcentr
therapeut
target
ebov
transmiss
occur
exposur
infect
bodi
fluid
tissu
mucou
membran
nonintact
mean
incub
period
day
rang
initi
sign
symptom
nonspecif
includ
fever
myalgia
malais
reliabl
distinguish
endem
ill
africa
includ
malaria
enter
wherea
mild
ill
describ
patient
develop
sever
diseas
within
day
symptom
onset
massiv
gastrointestin
fluid
loss
l
per
day
due
vomit
wateri
diarrhea
may
result
progress
dehydr
hypovolem
shock
even
set
adequ
fluid
electrolyt
replac
sequenti
multiorgan
failur
may
occur
ebov
infect
multipl
organ
cell
type
throughout
bodi
notabl
except
lymphocyt
indirectli
deplet
earli
infect
organ
injuri
due
direct
viral
indirect
hostmedi
respons
result
sever
complic
includ
meningoenceph
uveiti
respiratori
failur
secretori
diarrhea
disord
coagul
renal
failur
hepat
necrosi
myositi
clinic
present
laboratori
valu
viral
kinet
clinic
manag
evd
patient
west
africa
europ
unit
state
outbreak
recent
pauciti
inform
regard
ebov
pathogenesi
human
primarili
due
limit
frequenc
evd
outbreak
prior
limit
present
sampl
acquisit
infect
patient
field
well
overal
size
patient
cohort
larg
contradictori
find
regard
immun
respons
surviv
succumb
evd
confound
understand
ebov
pathogenesi
human
patient
exampl
villing
et
al
report
serum
cytokin
concentr
includ
elev
patient
fatal
infect
comparison
contrast
addit
studi
suggest
fatal
infect
instead
relat
gener
immunosuppress
includ
investig
sudv
infect
human
sanchez
et
al
demonstr
limit
chang
express
level
cytokin
fa
antigen
fa
ligand
pbmc
infect
patient
rel
found
uninfect
furthermor
investig
fatal
infect
evd
patient
wauquier
et
al
confound
role
host
immun
respons
fatal
evd
hypersecret
multipl
cytokin
growth
factor
decreas
secret
lymphocytederiv
cytokin
associ
fatal
date
investig
host
gene
express
ebovinfect
patient
report
although
limit
data
avail
anim
model
infect
vitro
investig
studi
pbmc
ebovinfect
crabeat
macaqu
rubin
et
al
found
notabl
chang
earli
stage
infect
day
howev
broad
chang
observ
day
postinfect
proinflammatori
cytokin
chemokin
upregul
day
postinfect
rel
healthi
multipl
gene
relat
apoptosi
includ
famili
member
multipl
caspas
fasassoci
death
domain
protein
tnf
superfamili
member
also
upregul
late
time
point
ifnregul
gene
upregul
day
postinfect
remain
studi
day
yan
et
al
investig
pbmc
gene
express
ebovinfect
rhesu
macaqu
without
anticoagul
administr
untreat
anim
display
upregul
immun
respons
gene
b
cell
receptor
signal
intermedi
nk
cell
mediat
cytotox
leukocyt
activ
lymphocyt
activ
compar
anticoagulanttr
anim
earli
stage
infect
express
level
gene
cluster
fell
preinfect
level
latestag
infect
contrast
gene
relat
defens
respons
apoptosi
wound
inflamm
coagul
leukocyt
activ
remain
elev
earli
latestag
infect
follow
isol
restv
subsequ
investig
demonstr
pig
suscept
restv
ebov
infect
preferenti
target
macrophag
lung
recent
nfon
et
al
demonstr
ebov
infect
pig
result
upregul
chemokin
express
begin
day
postinfect
compar
mockinfect
pronounc
chang
gene
express
found
day
postinfect
includ
upregul
broad
set
cytokin
resistin
chemokin
amcfii
cell
adhes
protein
selectin
antimicrobi
protein
palat
lung
nasal
epithelium
clone
protein
proapoptot
molecul
multipl
caspas
caspas
recruit
domaincontain
protein
card
apoptosisassoci
tyrosin
kinas
aatk
fa
fasassoci
protein
death
domain
fadd
tnf
receptorassoci
factor
protein
protein
addit
express
multipl
gene
relat
microbi
sens
pattern
recognit
receptor
antivir
respons
isg
upregul
lung
infect
anim
although
local
cytokin
respons
pig
human
nhp
differ
cours
ebov
infect
local
respons
lung
pig
versu
predominantli
system
respons
human
nhp
cytokin
profil
pig
human
nhp
quit
similar
exampl
comparison
porcin
ebov
infect
demonstr
multipl
gene
express
similar
two
speci
ie
caspas
famili
member
also
like
direct
comparison
data
set
would
like
yield
mani
common
gene
signatur
conserv
ident
well
direction
upregul
vs
downregul
macrophag
earli
target
ebov
infect
support
highlevel
viral
replic
ebov
attach
entri
human
macrophag
vitro
induc
proinflammatori
mediat
includ
earli
h
noncardiogen
pulmonari
edema
recogn
complic
evd
human
autopsi
data
support
alveolar
macrophag
target
ebov
infect
ebov
infect
alveolar
macrophag
vitro
result
earli
transient
increas
cytokin
chemokin
support
paracrinesolubl
mediat
inflamm
may
contribut
vascular
leakag
lung
gene
express
respons
ebov
marvinfect
cell
result
global
suppress
antivir
respons
includ
tolllik
receptor
tlr
protein
kinas
r
pkr
mediat
howev
signal
transduc
activ
transcript
stat
phosphoryl
ebov
marvinfect
cell
differenti
modul
ebovmedi
ifn
inhibit
well
character
thought
attribut
ebov
protein
interestingli
restv
infect
induc
clinic
ill
human
result
activ
ifnstimul
gene
isg
hepatocyt
earli
target
ebov
infect
directli
contribut
diffus
hepat
necrosi
observ
fatal
case
ebov
infect
cell
evalu
kinom
analys
shed
light
liver
pathogenesi
ebov
infect
cell
result
tempor
modul
signal
pathway
compar
mockinfect
cell
pathway
ora
demonstr
multipl
signal
pathway
upregul
h
post
ebov
infect
furthermor
respons
associ
chang
express
pattern
multipl
cellular
protein
associ
mesenchymelik
transit
includ
upregul
matrix
metalloproteinas
ncadherin
fibronectin
downregul
ecadh
claudin
process
cell
lose
polar
celltocel
adhes
transform
mesenchym
stem
cell
contribut
wound
heal
organ
fibrosi
howev
role
event
ebov
infect
remain
elucid
addit
analysi
demonstr
inhibit
erkmapk
pkc
pathway
kinas
inhibitor
reduc
ebov
replic
administ
prophylact
therapeut
support
observ
subset
kinas
inhibitor
administ
ebovinfect
mice
reduc
lethal
defin
mechan
kinas
inhibitor
show
benefit
model
better
clarifi
role
potenti
therapeut
clinic
epidemiolog
inform
regard
human
mpxv
diseas
deriv
enhanc
surveil
campaign
congo
work
demonstr
human
mpxv
infect
ill
larg
mirror
discret
ordinari
incub
period
virus
varv
mpxv
day
initi
febril
prodrom
period
day
prodrom
period
normal
accompani
fever
headach
backach
malais
rash
period
smallpox
mpxv
includ
lesion
appear
desquam
normal
occur
day
postinfect
highli
similar
appear
distribut
progress
smallpox
mpxvassoci
rash
progress
macular
papular
vesicular
pustular
phase
second
febril
period
occur
lesion
becom
pustular
often
associ
deterior
condit
patient
lymphadenopathi
maxillay
cervic
inguin
often
associ
mpxv
infect
prior
concomit
rash
develop
absent
varv
infect
postul
reflect
effect
gener
host
immun
respons
mpxv
infect
compar
varv
howev
yet
sever
complic
note
late
cours
mpxv
infect
includ
pulmonari
distress
bronchopneumonia
corneal
scar
perman
vision
loss
sever
dehydr
due
excess
vomit
diarrhea
may
also
occur
longterm
sequela
survivor
commonli
associ
pit
scar
although
mpxv
infect
human
record
four
decad
littl
inform
regard
host
immun
respons
cours
natur
infect
diseas
present
highli
similar
mpxv
varv
infect
postul
immun
respons
would
like
highli
conserv
recent
johnston
et
al
provid
first
empir
evid
relationship
cytokin
respons
diseas
sever
mpxv
serum
cytokin
analyz
patient
confirm
mpxv
infect
rang
mild
sever
assess
smallpox
lesion
score
serum
concentr
rant
elev
diseas
group
mild
sever
compar
normal
serum
concentr
concentr
also
elev
diseas
group
proport
diseas
sever
howev
patient
seriou
mpxv
diseas
significantli
higher
concentr
compar
diseas
group
mpxv
infect
result
elev
mild
case
significantli
elev
level
moder
sever
diseas
group
serum
concentr
elev
across
diseas
group
howev
patient
seriou
diseas
significantli
higher
serum
level
mild
sever
mpxv
diseas
gmcsf
level
significantli
elev
seriou
mpxv
diseas
compar
normal
serum
rang
basi
observ
mpxv
infect
result
promin
helper
dampen
respons
transcriptom
analys
larg
employ
vitro
investig
molecular
pathogenesi
mpxv
infect
alkhalil
et
al
investig
host
transcriptom
respons
mpxv
infect
first
cycl
viral
replic
h
postinfect
rhesu
macaqu
kidney
epitheli
interestingli
mpxv
infect
result
strong
downregul
host
transcript
respons
transcript
met
author
criteria
signific
transcript
found
downregul
postinfect
time
point
compar
function
analysi
time
point
suggest
primari
biolog
function
associ
downregul
transcript
respons
larg
relat
cell
morpholog
cell
develop
metabol
respons
posttransl
modif
canon
pathway
analysi
demonstr
gener
conserv
ident
overrepres
pathway
time
point
includ
multipl
growth
factor
signal
pathway
signal
cell
cyclerel
pathway
recent
bourquain
et
al
investig
host
transcriptom
respons
mpxvinfect
hela
cell
cervic
epitheli
cell
h
postmpxv
infect
transcript
analyz
found
chang
gene
express
contrast
alkhalil
et
al
major
transcript
found
upregul
compar
mockinfect
control
function
analysi
transcript
chang
gene
express
demonstr
strong
overrepresent
gene
involv
neg
regul
mapk
signal
intracellular
protein
cascad
posit
regul
pathway
relat
tolllik
receptor
signal
chemotaxi
regul
leukocyt
migrat
also
predict
data
investig
rubin
et
al
compar
tempor
host
transcriptom
respons
mpxv
multipl
human
cell
target
mpxv
includ
primari
macrophag
primari
fibroblast
hela
trasncriptom
mpxvinfect
fibroblast
found
signific
chang
mpxv
infect
result
deplet
gene
factor
interestingli
mpxv
infect
result
broad
repress
mani
transcript
relat
innat
immun
respons
cell
type
test
contrast
inactiv
mpxv
result
strong
upregul
innat
immun
respons
cell
type
also
note
mpxv
infect
result
strong
cytopath
effect
across
cell
type
contrast
almost
univers
repress
innat
immun
respons
human
mpxv
infect
infect
model
mpxv
variou
anim
speci
demonstr
congo
basin
mpxv
clade
virul
west
african
mpxv
clade
howev
pauciti
inform
regard
underli
molecular
mechan
mitig
virul
differ
furthermor
previou
investig
focus
gene
express
proteom
chang
mpxv
infect
focus
sole
congo
basin
mpxv
address
host
kinom
analysi
perform
congo
basin
west
african
mpxvinfect
human
monocyt
host
cell
target
genom
mpxv
clade
demonstr
consider
divers
region
code
host
respons
modifi
protein
particular
gene
associ
antiapoptot
activ
postul
virul
differ
two
mpxv
clade
may
relat
differenti
modul
host
cellular
respons
hierarch
cluster
kinom
data
set
suggest
limit
similar
level
host
kinas
modul
two
mpxv
clade
congo
basin
mpxv
kinom
data
set
cluster
strongli
kinom
data
set
cpxvinfect
monocyt
moder
vacvinfect
monocyt
data
set
cpxv
vacv
caus
seriou
diseas
human
pathway
ora
kinom
data
demonstr
congo
basin
mpxv
infect
result
strong
downregul
larg
proport
host
cell
respons
notabl
apoptosi
comparison
west
african
mpxv
biolog
valid
fluorescenceactiv
cell
sort
fac
caspas
activ
analys
confirm
phenomenon
perspect
individu
phosphoryl
event
kinom
data
also
suggest
akt
phosphoryl
increas
congo
basin
mpxvinfect
cell
compar
west
african
mpxvinfect
cell
pharmacolog
inhibit
akt
phosphoryl
result
inhibit
congo
basin
mpxv
viru
yield
wherea
west
african
mpxv
unaffect
prior
investig
cpxv
vacv
demonstr
pharmacolog
inhibit
akt
result
decreas
viral
yield
overal
investig
provid
signific
insight
host
cellular
respons
differ
two
mpxv
clade
emerg
reemerg
pathogen
continu
threat
global
health
recent
year
diseas
outbreak
associ
sar
influenza
pandem
also
demonstr
pathogen
consider
effect
local
nation
intern
economi
consequ
region
outbreak
emerg
reemerg
pathogen
deleteri
effect
global
stabil
thu
prudent
concert
effort
employ
assimil
data
bridg
clinic
molecular
inform
investig
pathogen
effort
provid
consider
context
regard
molecular
event
potenti
clinic
manifest
pathogenesi
also
better
inform
design
implement
novel
therapeut
end
global
analys
host
molecular
respons
provid
consider
insight
complex
molecular
event
underli
cellular
respons
inde
transcriptom
analys
provid
import
inform
regard
host
transcript
respons
emerg
reemerg
pathogen
infect
investig
often
provid
critic
insight
kinet
host
immun
respons
cours
infect
well
mechanist
inform
regard
cellular
intermedi
involv
process
howev
role
ptm
regul
event
captur
tradit
transcriptom
technolog
particular
role
kinasemedi
regul
cell
signal
pathway
remain
poorli
understood
given
central
role
kinas
regul
cellular
process
eg
homeostasi
metabol
prolifer
stress
respons
inher
import
futur
investig
also
address
role
kinom
cellular
respons
pathogen
insult
furthermor
kinom
also
provid
mechan
identif
novel
therapeut
target
base
direct
assess
activ
state
cell
signal
pathway
exampl
proinflammatori
respons
earli
stage
infect
particular
dysregul
specif
cytokin
cell
signal
event
contribut
may
repres
potenti
therapeut
target
earli
stage
highconsequ
viral
pathogen
infect
howev
select
immunomodulatori
therapeut
target
dysregul
host
respons
complic
regulatori
event
ie
kinasemedi
cell
signal
event
occur
upstream
chang
gene
express
addit
mrna
subject
varieti
regulatori
process
includ
gene
silenc
mrna
stabil
translat
effici
protein
turnov
enzymesubstr
subcellular
sequestr
andor
protein
activationrepress
ptm
thu
standpoint
therapeut
discoveri
sole
relianc
technolog
global
investig
host
respons
account
regulatori
process
role
ptm
modul
cellular
respons
could
imped
identif
efficaci
therapeut
end
kinom
analysi
may
also
facilit
identif
immunomodulatori
therapeut
gain
licensur
analysi
quantifi
biolog
event
kinasemedi
phosphoryl
identifi
novel
host
therapeut
target
therapeut
could
designeddevelop
furthermor
kinas
inhibitor
may
serv
primari
adjunct
therapi
emerg
infecti
diseas
addit
preclin
data
increas
number
kinas
inhibitor
gain
regulatori
approv
cancer
maladi
suggest
approach
feasibl
efficaci
perspect
review
kinom
investig
identifi
sever
therapeut
target
licens
kinas
inhibitor
impair
viral
replic
vitro
reduc
sever
diseas
vivo
tabl
exampl
demonstr
erkmapk
signal
pathway
role
viral
propag
merscov
inde
licens
kinas
inhibitor
target
pathway
ie
everolimu
selumetinib
trametinib
result
decreas
viral
replic
vitro
ad
prior
follow
infect
furthermor
pharmacolog
inhibit
pkc
follow
ebov
infect
provid
partial
protect
lethal
model
evd
note
although
modul
individu
kinas
may
suppress
effect
infect
ie
viral
replic
might
provid
level
inhibit
requir
complet
negat
viral
escap
addit
given
abil
mani
cell
signal
pathway
signal
canon
noncanon
mechan
inhibit
singl
intermediari
point
within
pathway
may
provid
overal
level
inhibit
requir
negat
deleteri
respons
ie
viral
replic
chang
cellular
phenotyp
etc
thu
although
previou
investig
demonstr
individu
kinas
cell
signal
pathway
may
repres
novel
target
antiinfect
therapi
prudent
futur
investig
also
examin
combin
inhibitor
efficaci
antiinfect
activ
furthermor
target
cell
signal
pathway
near
origin
point
cell
signal
cascad
also
examin
like
repres
stronger
inhibitori
target
given
gener
reduc
branch
cell
signal
network
near
cell
receptor
addit
hostdirect
therapeut
target
kinom
also
confer
abil
identifi
novel
inhibitor
pathogen
detail
character
viral
life
cycl
hostmedi
ptm
particular
kinasemedi
phosphoryl
implic
viral
life
cycl
pathogenesi
sever
member
order
mononegaviral
includ
thu
therapeut
target
kinas
may
repres
novel
therapeut
strategi
employ
modul
hostcentr
pathogencentr
molecular
event
infect
exampl
silico
predict
viral
protein
phosphoryl
site
provid
mechan
construct
ultim
annot
viral
protein
ptm
critic
viral
life
cycl
furthermor
use
kinom
peptid
array
extend
beyond
human
kinom
extend
varieti
anim
suggest
interspeci
phenotyp
variabl
may
reflect
differ
phosphoryl
site
found
within
thu
develop
speciesspecif
kinom
peptid
array
provid
addit
util
kinom
analysi
peptid
array
repres
tradit
laboratori
anim
speci
mous
guinea
pig
nonhuman
primat
employ
detail
speciesspecif
host
respons
result
analys
overlap
describ
previous
analysi
human
infect
may
inform
select
appropri
anim
model
meet
regulatori
approv
fda
anim
efficaci
taken
togeth
inher
import
futur
investig
emerg
reemerg
pathogen
address
complex
natur
biolog
respons
thu
molecular
investig
pathogenesi
guid
avail
knowledg
regard
clinic
patholog
manifest
diseas
inde
technolog
provid
granular
precis
molecular
event
potenti
cellular
respons
cours
infect
assist
investig
emerg
reemerg
pathogen
identif
novel
therapeut
target
end
kinomicsbas
analys
host
respons
provid
mechan
directli
address
cellular
event
level
specif
cell
signal
phenomena
underli
biolog
respons
ultim
clinic
present
diseas
emerg
infecti
pathogen
